Business Wire

Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use ...

QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory ...
Yahoo Finance

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment ...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Business Insider

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment ...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH) , a clinical-stage biotechnology company developing an innovative ...

Integrated Quantum Technologies (DBA) Files Provisional Patent for Post-Quantum AI ...

Integrated Cyber Solutions Inc. (CSE: ICS) (OTCQB: IGCRF) (FSE: Y4G) dba Integrated Quantum Technologies ("IQT" or the ...
Nasdaq

Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use ...

QUEBEC CITY--(BUSINESS WIRE)-- Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory ...
manilatimes

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment ...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. ("Raphael Pharmaceutical” or the "Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...